BG BAU Berufsgenossenschaft der Bauwirtschaft

Rückwärts blättern Vorwärts blättern


[1] Ahlbom, A.; Axelson, O.; Hansen, E.S.; Hogstedt, C.; Jensen, U.J.; Olsen, J., 1990 Interpretation of "negative" studies in occupational epidemiology Scandinavian Journal of Work, Environment and Health, 16, 1990, 153-157

[2] Ahrens, W.; Stewart, P., 2003 Retrospective exposure assessment In: Nieu-wenhuijsen, M.J., Exposure Assessment in Occupational and Environmental Epidemiology Oxford; New York: Oxford University Press, 2003

[3] Ahrens, W.; Behrens, T.; Mester, B.; Schmeißer, N., 2008 Epidemiologie der Arbeitswelt Bundesgesundheitsblatt (im Druck)

[4] Attfield, M.D.; Costello, J., 2004 Quantitative exposure-response for silica dust and lung cancer in Vermont granite workers American Journal of Industrial Medicine, 45, 2004, 129-138

[5] Becher, H.; Steindorf, K., 1993 Epidemiologische Methoden und Wege der Risikoabschätzung Informatik, Biometrie und Epidemiologie in Medizin und Biologie, 24, 1993, 14-27

[6] Blair, A.; Burg, J.; Foran, J.; Gibb, H.; Greenland, S.; Morris, R.; Raabe, G.; Savitz, D.; Teta, J.; Warteberg, D.; et al., 1995 Guidelines for application of meta-analysis in environmental epidemiology. ILSI Risk Science Institute Regulatory Toxicology and Pharmacology, 22, 1995, 189-197

[7] Bolt, H.; Huici-Montagud, A., 2007 Strategy of the scientific committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens ,Archives of Toxicology, Online-Veröffentlichung, Meeting Reports, November 2007

[8] Boobis, A.; Cohen,S.; Dellarco, V.; Meek, M.E.; Vickers, C.; Willcock, D.; Farland, W., 2006 IPCS Framework for analyzing the relevance of a cancer mode of action for humans Critical Reviews in Toxicology, 36 (10), 781-792

[9] BAuA, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, 2005 Toleranz-schwelle und Akzeptanzschwelle für Gesundheitsrisiken am Arbeitsplatz, 2004-2005, Vorhaben-Nr. F 2010 und F 2080, Auftragsnehmer: FoBiG GmbH, Kalberlah, F., Dortmund, 2005

[10] Bundesministerium für Arbeit und Soziales, 2005 Verordnung zum Schutz vor Gefahren (Gefahrstoffverordnung - GefStoffV); 2005

[11] Butterworth, B.E., 2006 A classification framework and practical guidance for establishing a mode of action for chemical carcinogens Regulatory Toxicology and Pharmacology, 45, 2006, 9-23

[12] Chen,J.; Kodell, R.L.; Gaylor, D.W., 1988 Using the Biological Two-Stage Model to Assess Risk from Short-Term Exposures Risk Analysis, 8 (2), 1988, 223–230

[13] Cohen, S.M.; Meek, M.E.; Klaunig, J.E.; Patton, D.E.; Fenner-Crisp, P.A., 2003 The human relevance of information on carcinogenic modes of action: overview. Special issue: cancer modes of action and human relevance Critical Reviews in Toxicology, 33, 2003, 581-589

[14] Cordier, S.; Stewart, P., 2005 Exposure Assessment In: Ahrens, W.; Pigeot, I., Handbook of Epidemiology Berlin; Heidelberg; New York: Springer, 2005

[15] Crump, K.S.; Howe, R.B., 1984 The multistage model with a time-dependent dose pattern: application to carcinogenic risk assessment Risk Analysis, 4, 1984, 163-176

[16] Derelanko und Hollinger, 2002 Handbook of Toxicology, CRC Press, Boca Raton, Fl., 2002

[17] DFG, Deutsche Forschungsgemeinschaft, 2007 MAK- und BAT-Werte-Liste 2007. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Mitteilung 43 WILEY-VCH Verlag GmbH, Weinheim, 2007

[18] DGEpi, Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie, 2004 Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP) Download unter:

[19] Doll, R.; Wald, N.J., 1994 Interpretation of negative epidemiological evidence for carcinogenicity IARC Scientific Publications Vol. 65 IARC, International Agency for Research on Cancer, Lyon, 1994

[20] Dybing, E.; Sanner, T.; Roelfzema, H.; Kroese, D.; Tennant, R.W., 1997 T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity Pharmacology & Toxicology, 80, 1997, 272-279

[21] EC, European Commission, 1999 Guidelines for setting specific concentration limits for carcinogens in Annex 1 of Directive 67/548/EEC. Inclusion of potency considerations European Commission, Brussels, 1999

[22] EC, European Commission, 2006 Technical Guidance Document in Support of the Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and the Commission Regulation (EC) 1488/94 on Risk Assessment for Existing Substances and Directive 98/8/EC of the European Parliament and of the Council Concerning the Placing of Biocidal Products on the Market. Human Health Risk Characterisation, Revised Chapter, Final Draft Joint Research Centre, Institute for Health and Consumer Protection, European Chemicals Bureau, Ispra, Italy 2006

[23] EFSA, European Food Safety Authority, 2005 Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic (Request No EFSA-Q-2004-020) (Adopted on 18 October 2005) The EFSA Journal, 282, 2005, 1-31

[24] EPA, Environmental Protection Agency, 2000 Benchmark Dose Technical Guidance Document. Draft U.S. Environmental Protection Agency, Washington, DC, 2000

[25] EPA, Environmental Protection Agency, 2005 Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F Risk Assessment Forum. U.S. Environmental Protection Agency, Washington, DC, 2005

[26] EU, Europäische Union, 2004 Richtlinie 2004/37/EG über den Schutz der Arbeitnehmer gegen Gefährdung durch Karzinogene oder Mutagene bei der Arbeit (Krebsrichtlinie) 2004

[27] EU, Europäische Union, 2006 Verordnung (EG) Nr. 1907/2006 des Europäischen Parlaments und des Rates vom 18. Dezember 2006 zur Registrierung, Bewertung, Zulassung und Beschränkung chemischer Stoffe (REACH), zur Schaffung einer Europäischen Agentur für chemische Stoffe, zur Änderung der Richtlinie 1999/45/EG und zur Aufhebung der Verordnung (EWG) Nr. 793/93 des Rates, der Verordnung (EG) Nr. 1488/94 der Kommission, der Richtlinie 76/769/EWG des Rates sowie der Richtlinien 91/155/EWG, 93/67/EWG, 93/105/EG und 2000/21/EG der Kommission; 2006

[28] EU, Europäische Union, 2007 Richtlinie 67/548/EWG, Anhang VI - Allgemeine Anforderungen für die Einstufung und Kennzeichnung gefährlicher Stoffe und Zubereitungen, letzte Änderungsrichtlinie 2007

[29] FDA, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001 Guidance for Industry. Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals

[30] Foth, H.; Degen, G.H.; Bolt, H.M., 2005 New aspects in the classification of carcinogens Arhiv za Higijenu Rada i Toksikologiju, 56, 2005, 167-175

[31] Goldbohm, R.A.; Tielemans, E.L.J.P.; Heederik, D.; Rubingh, C.M.; Dekkers, S.; Willems, M.I.; Kroese, E.D., 2006 Risk estimation for carcinogens based on epidemiological data: A structured approach, illustrated by an example on chromium Regulatory Toxicology and Pharmacology, 44, 2006, 294-310

[32] HEI-AR, Health Effects Institute - Asbestos Research, 1991 Asbestos in public and commercial buildings: A literature review and synthesis of current knowledge Health Effects Institute - Asbestos Research, Cambridge, MA, 1991

[33] Hengstler, J.G.; Degen, G.H.; Foth, H.; Bolt, H.M., 2006 Thresholds for specific classes of genotoxic carcinogens: a new strategy for carcinogenicity categorisation of chemicals to be published in SIIC, in press, 2006

[34] Kalberlah, F.; Schneider, K., 1998 Quantifizierung von Extrapolationsfaktoren. Endbericht des Forschungsvorhabens Nr. 116 06 113 des Umweltbundesamtes Schriftenreihe der Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Dortmund, Fb 796 Wirtschaftsverlag NW, Bremerhaven, 1998

[35] Kirkland, D.J.; Aardema, M.; Banduhn, N.; Carmichael, P.; Fautz, R.; Meunier, J.-R.; Pfuhler, S., 2007a In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results Mutagenesis, 22, 2007, 161-175

[36] Kirkland, D.; Pfuhler, S.; Tweats, D.; Aardema, M.; Corvi, R.; Darroudi, F.; Elhajouji, A.; Glatt, H.; Hastwell, P.; Hayashi, M.; Kasper, P.; Kirchner, S.; Lynch, A.; Marzin, D.; Maurici, D.; Meunier, J.R.; Müller, L.; Nohynek, G.; Parry, J.; Parry, E.; Thybaud, V.; Tice, R.; van Benthem, J.; Vanparys, P.; White, P., 2007b How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary followup animal tests: Report of an ECVAM Workshop Mutation Research, 628, 2007, 31-55

[37] Kirman, C.R.; Sweeny, L.M.; Teta, M.J.; Sielken, R.L.; Valdez-Flores, C.; Albertini, R.J.; Gargas, M.L., 2004 Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide Risk Analysis, 24, 2004, 1165-1183

[38] Kromhout, H., 1994 From eyeballing to statistical modelling: methods for assessment of occupational exposure PhD Thesis, Agricultural University of Wageningen, 1994

[39] Last J.M, 2001 A dictionary of epidemiology, 4th ed.. Oxford: Oxford University Press, 2001

[40] Lutz, W.K., 2000 A true threshold dose in chemical carcinogenesis cannot be defined for a population, irrespective of the mode of action Human & Experimental Toxicology, 19 (10), 2000, 566-568; discussion 571-572

[41] McConnell, E.E.; Swenberg, J.A., 1994 Review of styrene and styrene oxide longterm animal studies Critical Reviews in Toxicology, 24, Suppl., 1994, 49-55

[42] McConnell, E.E.; Solleveld, H.A.; Swenberg, J.A.; Boorman, G.A., 1986 Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies Journal of the National Cancer Institute, 76, 1986, 283-289

[43] Meek, M.E.; Bucher, J.R.; Cohen, S.M.; Dellarco, V.; Hill, R.N.; Lehman-McKeeman, L.D.; Longfellow, D.G.; Pastoor, T.; Seed, J.; Patton, D.E., 2003 A framework for human relevance analysis of information on carcinogenic modes of action: special issue: cancer modes of action and human relevance Critical Reviews in Toxicology, 33, 2003, 591-653

[44] Neumann, H.-G., 2006a Die Risikobewertung von Kanzerogenen und die Wirkungsschwelle, Teil I Bundesgesundheitsblatt, 49, 2006, 665-674

[45] Neumann, H.-G., 2006b Die Risikobewertung von Kanzerogenen und die Wirkungsschwelle, Teil II Bundesgesundheitsblatt, 49, 2006, 818-823

[46] Neumann, H.-G., 2006c Die Risikobewertung von Kanzerogenen und die Wirkungsschwelle, Teil III Bundesgesundheitsblatt, 49, 2006, 911-920

[47] o.V., 1998 Kriterien für die Ableitung von gesundheitsbasierten Luftgrenzwerten bei limitierter Datenlage Bundesarbeitsblatt,10, 1998, 74-76

[48] Preston, R.J.; Williams, G.M., 2005 DNA-reactive carcinogens: mode of action and human cancer hazard Critical Reviews in Toxicology, 35, 2005, 673-683

[49] Rice, F.L.; Park, R.; Stayner, L.; Smith, R.; Gilbert, S.; Checkoway, H., 2001 Crystalline silica exposure and lung cancer mortality in diatomaceous earth industry workers: a quantitative risk assessment Occupational and Environmental Medicine, 58, 2001, 38-45

[50] Roller, M., 2005 Persönliche Mitteilung, Arbeitskreis CMR des Unterausschuss III, Ausschuss für Gefahrstoffe, März 2005

[51] Roller, M.; Akkan, Z.; Hassauer, M.; Kalberlah, F., 2006 Risikoextrapolation vom Versuchstier auf den Menschen bei Kanzerogenen Fb 1078, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Dortmund/Berlin/Dresden Wirtschaftsverlag NW, Bremerhaven, 2006

[52] Sanner, T.; Dybing, E.; Willems, M.I.; Kroese, E.D., 2001 A simple method for quantitative risk assessment of nonthreshold carcinogens based on the dose descriptor T25 Pharmacology & Toxicology, 88, 2001, 331-341

[53] SCOEL, Scientific Committee on Occupational Exposure Limits, 2003 Recommendation from the Scientific Committee on Occupational Exposure Limits: risk assessment for 1,3-butadiene SCOEL/SUM/75 final. November 2003

[54] Seed, J.; Carney, E.W.; Corley, R.A.; Crofton, K.M.; DeSesso, J.M.; Foster, P.M.D.; Kavlock, R.; Kimmel, G.; Klaunig, J.; Meek, M.E.; Preston, R.J.; Slikker, W.; Tabacova, S.; Williams, G.M.; Wiltse, J.; Zoeller, R.T.; Fenner-Crisp, P.; Patton, D.E., 2005 Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data Critical Reviews in Toxicology, 35, 2005, 664-672

[55] Sorahan, T.; Hamilton, L.; Gompertz, D.; Levy, L.S.; Harrington, J.M., 1998 Quantitative risk assessments derived from occupational cancer epidemiology: a worked example Annals of Occupational Hygiene, 42, 1998, 347-352

[56] Statistisches Bundesamt Deutschland, 2006

[57] Statistisches Jahrbuch für die Bundesrepublik Deutschland 2006,vollanzeige.csp&ID=1019209

[58] Stayner, L.; Smith, R.; Bailer, A.J.; Luebeck, E.G.; Moolgavkar, S.H., 1995 Modeling epidemiologic studies of occupational cohorts for the quantitative assessment of carcinogenic hazards American Journal of Industrial Medicine, 27, 1995, 155-170

[59] Stayner, L.; Dankovic, D.; Smith, R.; Steenland, K., 1998 Predicted lung cancer risk among miners exposed to diesel exhaust particles American Journal of Industrial Medicine, 34, 1998, 207-219

[60] Stayner, L.T.; Dankovic, D.A.; Smith, R.J.; Gilbert, S.J.; Bailer, A.J., 2000 Human cancer risk and exposure to 1,3-butadiene - a tale of mice and men Scandinavian Journal of Work, Environment and Health, 26, 2000, 322-330

[64] Steenland, K.; Mannetje, A.; Boffetta, P.; Stayner, L.; Attfield, M.; Chen, J.; Dosemeci, M.; DeKlerk, N.; Hnizdo, E.; Koskela, R.-S.; Checkoway, H., 2001 Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silicaexposed workers: an IARC multicentre study Cancer Causes & Control, 12, 2001, 773-784

[65] Streffer, C.; Bolt, H.M.; Follesdal, D.; Hall, P.; Hengstler, J.G.; Jacob, P.; Oughton, D.; Priess, K.; Rehbinder, E.; Swaton, E., 2004 Environmental standards -dose-effect relations in the low dose range and risk evaluation Springer Verlag Berlin, 2004

[66] Umweltbundesamt, 2003 Vergleich der Verfahren zur Ableitung gesundheitsbezogener Wirkungsschwellen (Benchmark - NOAEL). Abschlussbericht. Forschungs- und Entwicklungsvorhaben FKZ 201 65 201/01 (Autoren: Kalberlah, F. und Hassauer, M.) Freiburg/Berlin, 2003

[67] Van Wijngaarden, E.; Hertz-Picciotto, I., 2004 A simple approach to performing quantitative cancer risk assessment using published results from occupational epidemiology studies The Science of the Total Environment, 332, 2004, 81-87

[68] WHO, World Health Organization, o.J. The IPCS Conceptual Framework for Cancer Risk Assessment

Webcode: M438-53